SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950123-22-003537
Filing Date
2022-03-18
Accepted
2022-03-18 17:02:30
Documents
6
Effectiveness Date
2022-03-18

Document Format Files

Seq Description Document Type Size
1 FORM S-8 janx_s-8_march_2022.htm S-8 150197
2 EX-5.1 janx-ex5_1.htm EX-5 16033
3 EX-23.1 janx-ex23_1.htm EX-23 2938
4 EX-FILING FEES janx-ex99.htm EX-FILING FEES 40027
5 GRAPHIC img151594875_0.jpg GRAPHIC 2127
6 GRAPHIC img151594875_1.jpg GRAPHIC 2127
  Complete submission text file 0000950123-22-003537.txt   216336
Mailing Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037
Business Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037 858-750-4700
Janux Therapeutics, Inc. (Filer) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263712 | Film No.: 22753277
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences